17
Views
11
CrossRef citations to date
0
Altmetric
Experimental and Clinical Research

Twenty-Year Follow-Up of Osteosarcoma of the Extremity Treated with Adjuvant Chemotherapy

Pages 582-588 | Published online: 18 Jul 2013

REFERENCES

  • Bacci G, Gherlinzoni F, Picci P, et al. Adriamycin-Methotrexate high dose versus Adriamycin-Methotrexate mod-erate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. Eur J Cancer Clin Oncol 1986; 22: 1337–1345.
  • Link MP, Goorin AM, Miser AW et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314: 1600–1606.
  • Rosen G, Marcove RC, Caparros B, et al. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 1979; 43: 1221–1230.
  • Campanacci M, Bacci G, Berton' F, et al. The treat-ment of osteosarcoma of the extremities: twenty years experi-ence at the Istituto Ortopedico Rizzoli. Cancer 1981; 48: 1569–1581.
  • Bacci G, Ferrari S, Lan i S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoad-juvant chemotherapy. J Bone Joint Surg (Br) 2002; 84: 88–92.
  • Kotz R, Dominkus M, Zettl T, et al. Advances in bone tumor treatment in 30 years, with respect to survival and limb salvage. A single institution experience. Int Orthoped 2002; 26: 197–202.
  • Winkler K, Beron G, Kotz R. Neoadjuvant chemothera-py for osteogenic sarcoma: results of cooperative German /Austrian Study. J Clin Oncol 1984; 2: 617–624.
  • Bramwell VHC, Burgers M, Sneath R, et al. A compar-ison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992; 10: 5–15.
  • Souhami RL, Craft AW, Van der Eijeken JW, et al. Randomized trial of two regimens of chemotherapy in opera-ble osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350: 911–917.
  • Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan Kettering experience. J Clin Oncol 1992; 10: 5–15.
  • Link MP. The multiinstitutional osteosarcoma study; an update. Cancer Treat Res 1993; 62: 261–267.
  • Ferrari S, Bacci G, Picci P, et al. Long term follow up and post relapse survival in patients with nonmetastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997; 8: 765–771.
  • Fuchs N, Bielack SS, Epler D, et al. Long term results of the co-operative German Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9: 893–899.
  • Geidel S, Garn M, Gravinghoff L, et al. Cardiomyopathy after osteosarcoma treatment: a contribution on the cardiotoxicity of doxorubicin. Klin Pediatr 1991; 203: 257–261.
  • Howell S, Shalet S. Gonadal damage from chemothera-py and Radiotherapy. Endoc Metab Clin North Am 1998; 27: 927–943.
  • Byrne J, Mulvihill JJ, Meyer MH, et al. Effects of treat-ment on fertility in long-term survivors oh childhood or adoles-cent cancer. N Engl J Med 1987; 317: 1315–1321.
  • Hawkins MM. Is there evidence of a therapy related increase in germ cell mutation among childhood cancer sur-vivors? J Natl Cancer Inst 1991; 83: 1643-1650.
  • Longhi A, Porcu E, Petracchi S, et al. Reproductive functions in female patients treated with adjuvant and neoadju-vant chemotherapy for localized osteosarcoma of the extremi-ty Cancer 2000; 89: 1961-1965.
  • Robinson LL. Second primary cancers after childhood cancer. BMJ 1996; 312: 861–862.
  • Nicholson HS, Mulvihill JJ, Byrne J. Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarco-ma. Med Pediatr Oncol 1992; 20: 6–12.
  • Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occurring in survivors of osteosarcoma. Cancer 1997; 80: 960–965.
  • Bacci G, Ferrari S, Berton' F, et al. Long-term out-come for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the IOR/OS 2 protocol; an updated report. J Clin Oncol 2000; 18: 4016-4027.
  • Jaffe N, Smith E, Abelson HT, et al. Osteogenic sarco-ma: alteration in the pattern of pulmonary metastases with adjuvant chemotherapy. J Clin Oncol 1983; 1: 251–254.
  • Bacci G, Ferrari S, Longhi A, et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer 2001; 37: 32–38.
  • Giuliano A, Feig S, Eilber FR. Changing metastatic pat-tern in osteosarcoma. Cancer 1984; 54: 2160–2164.
  • Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 2003; 21: 1574-1580.
  • Dodds L, Marrett LD, Tomkins DJ, et al. Case control study of congenital anomalies in children of cancer patients. BMJ 1993; 307: 164–168.
  • Young JL, Ries LG, Silverberg E, et al. Cancer inci-dence, survival and mortality for children younger then age 15 years. Cancer 1986; 58: 598–602.
  • Green DM, Zevon MA, Lowrie G, et al. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991; 325: 141–146.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.